Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Carl von Ossietzky University of Oldenburg
Oldenburg, AlemaniaPublications in collaboration with researchers from Carl von Ossietzky University of Oldenburg (7)
2024
2022
2021
-
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Structure and absolute configuration of phenanthro-perylene quinone pigments from the deep-sea crinoid hypalocrinus naresianus
Marine Drugs, Vol. 19, Núm. 8
2020
2018
-
Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer
New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039